Member Info for mizman

Chief scientific advisor : need more testing.

Raty,

Nothing new. You must be joking. Confirmation of UK Government orders, and imminent sales from India and product margins to name a few.

Have you had some coffee this morning?

I think we have all underestimated the potential here. Product has already been shipped to India and we are in talks with Government (reasonable inference from presentation). CK mentioned sales potentialy from the end of July.

I suspect an order in the magnitude of millions is less than two weeks away. Surely that would rocket the SP over 80p, closely followed by UK Gov supply agreement. This has £1 short term written all over it.

Drop on **** poor volume.

[The latest research suggests] there is no guarantee that a vaccine will be found that confers lasting immunity,” adds Stephen Evans, professor of pharmacoepidemiology at the London School of Hygiene and Tropical Medicine. “It’s possible immunity will be short-lived or even non-existent. We await the results of the trials.”

There are three other bits of emerging Covid science that vaccine teams are keeping a close eye on – two encouraging and one a bit terrifying.

On the bright side, the virus itself seems stable with no major mutations yet recorded which would derail vaccine development. And the focus of nearly all vaccine teams on disrupting the virus’s ‘spike protein’ looks correct, with more and more research showing its importance.

On the dark side, there is a “nagging concern” that the worst cases of Covid-19 could actually be linked to T-cells generated by the common cold, adds Dr Edwards.

A review in Nature described this as the risk of ‘original antigenic sin’, where the presence of T cells triggers an inferior immune response that actually makes the disease worse.

“There’s no indication that this is the case, but it’s just possible that some vaccine candidates will trigger an immune response that makes the virus more severe”, said Dr Edwards. “You just need to look at dengue fever… there are four types, and you almost always have a more severe disease after the second infection”.

Let’s hope Covid does not take after dengue.

No it's not for us poor investors, its for the sake of the little pooches, ****atoes and bunny rabbits.

Why no mention of pet or alien antibody testing?

Wow Sam ******, is that an attempt to post a serious deramp?

All the shorter have bought back in. They knew it was weekly production.

Sales in August, so news is imminent.

They know it's per week but desperately working overtime to get Pis to sell.

I'm still holding for £1+ and it's coming soon. Just needs a few RNA's.

Definitely a sustained campaign to short the company. Will reverse when sales and profit margins are released. Watch out for the news flow over the next few weeks.

More like it.

Mr Investment, you have laid your cards on the table with that statement.

This company is not a charity. It will be selling millions of tests and the fact that the UK-RTC test will be competitively priced will guarantee sales in the millions.

Your trying to get up omega day and night. Take a break from the near 24 7 shifts. Get some sleep and be fresh for investors presentation.

Looks like some paid 40.5 for 31k of shares. Any thoughts?

£7m contract for just a chemical solution.

How big a contract will Omega/Malogic get for antibody and antigen tests? Almost there folks!

More bull**** than all the bulls of Africa can produce.

The man should hang his head in shame, or better still, a game hunter can make a trophy out of him.

Pressure increasing to do mass testing. Sky News gave the spineless minister a grilling on mass testing for everyone including asymptomatic.

That's the main point Chrishutch. Thoes who try to buy in any big chucks will push price dramatically up, hence plenty of small sales push price down.

Manipulation.